Stock PMVP PMV PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus PMV Pharmaceuticals, Inc.

Equities

PMVP

US69353Y1038

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
1.75 USD +2.34% Intraday chart for PMV Pharmaceuticals, Inc. +8.70% -43.55%
Apr. 12 Jefferies Starts PMV Pharmaceuticals With Buy Rating, $5 Price Target MT
Mar. 27 PMV Pharmaceuticals, Inc. Announces First Patient Dosed in Global Tumor-Agnostic Phase 2 PYNNACLE Trial for Rezatapopt in TP53 Y220c-Positive Solid Tumors CI

Evolution of the average Target Price on PMV Pharmaceuticals, Inc.

Price target over the last 5 years

History of analyst recommendation changes

37cd2f403fc566844a67a42d74523.vI42gRcZFyKXNCqgbCKByobm9_xUD34Ip6x2_thdTRo.68ROs2RxVHaibEzND2rsqLWej4k4Ryw944EZxoAqf1f0uFrsVGB5QO56ew~c7577aacdd2d71a9047bac4887d6c5f5

Analyst Recommendations on PMV Pharmaceuticals, Inc.

Jefferies Starts PMV Pharmaceuticals With Buy Rating, $5 Price Target MT
Ladenburg Thalmann Initiates PMV Pharmaceuticals at Buy With $7 Price Target MT
HC Wainwright Cuts Price Target on PMV Pharmaceuticals to $5 From $29, Maintains Buy Rating MT
HC Wainwright Adjusts PMV Pharmaceuticals Price Target to $29 From $35, Maintains Buy Rating MT
HC Wainwright Adjusts Price Target on PMV Pharmaceuticals to $35 From $36, Keeps Buy Rating MT
Oppenheimer Adjusts PMV Pharmaceuticals' Price Target to $15 From $28, Maintains Outperform Rating MT
HC Wainwright Adjusts PMV Pharmaceuticals' Price Target to $36 From $63, Keeps Buy Rating MT
Oppenheimer Adjusts PMV Pharmaceuticals Price Target to $28 From $33, Maintains Outperform Rating MT
Oppenheimer Adjusts PMV Pharmaceuticals Price Target to $33 From $30, Maintains Outperform Rating MT
Goldman Reduces PMV Pharmaceuticals' Price Target to $25 From $43, Buy Rating Kept MT
Oppenheimer Upgrades PMV Pharmaceuticals to Outperform From Perform, Sets $30 Price Target MT
PMV PHARMACEUTICALS : Goldman Sachs Upgrades PMV Pharmaceuticals to Buy From Neutral, Lifts Price Target to $43 From $35 MT
PMV PHARMACEUTICALS : Oppenheimer Initiates Coverage on PMV Pharmaceuticals With Perform Rating MT
PMV PHARMACEUTICALS : Guggenheim Starts PMV Pharmaceuticals at Buy With $56 Price Target MT
PMV PHARMACEUTICALS : HC Wainwright Starts PMV Pharmaceuticals at Buy With $63 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
1.75 USD
Average target price
5.667 USD
Spread / Average Target
+223.81%
High Price Target
7 USD
Spread / Highest target
+300.00%
Low Price Target
5 USD
Spread / Lowest Target
+185.71%

Consensus detail

Consensus revision (last 18 months)

Analysts covering PMV Pharmaceuticals, Inc.

Jefferies & Co.
Ladenburg Thalmann
HC Wainwright
Oppenheimer
Goldman Sachs
Guggenheim

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. PMVP Stock
  4. Consensus PMV Pharmaceuticals, Inc.